Results 201 to 210 of about 927,717 (352)

The Persisting Burden of Rheumatic Heart Disease: Insights From the Ina-RHD Study. [PDF]

JACC Asia
Hu H, Liu X.
europepmc   +1 more source

Rheumatic Heart Disease from the Standingpoint of View of the Medical Economy : Rheumatic Heart Disease as an Economical Disease

, 1966
Tachio Kobayashi, Naohide KUMAGAI, Toshio Nishimura   +2 more
openalex   +2 more sources

B cells and systemic sclerosis interstitial lung disease

Arthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman, Voon Ong, Christopher Denton   +2 more
wiley   +1 more source

The Impact of Acute Rheumatic Fever Diagnosis on Rheumatic Heart Disease Severity. [PDF]

Glob Heart
Williamson JM, Whalley G, Thornley S, Marangou J, Morris P, Francis JR, Wade V, Remenyi B.   +7 more
europepmc   +1 more source

Studies on the pathogenesis of rheumatic heart disease. An immunological relationship between group A streptococcus and heart tissue.

, 1977
Seiichi Kawakita
openalex   +2 more sources

Prognostic value of lupus anticoagulant and anti‐β2 glycoprotein I antibody in adverse pregnancy outcomes.

Arthritis &Rheumatology, Accepted Article.
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) immunoglobulin (Ig) G and IgM, and anti‐β2‐glycoprotein I (β2GPI) IgG and IgM. However, evidence supporting their prognostic value or treatment efficacy in improving live birth rates is limited.
Megumi Nonobe, Takahiro Otani, Hiroyuki Yoshihara, Shinobu Goto, Tamao Kitaori, Naomi Nishikawa, Yuichiro Fujieda, Tatsuya Atsumi, Mayumi Sugiura‐Ogasawara   +8 more
wiley   +1 more source

Serum metabolic profiling in rheumatic heart disease and degenerative aortic stenosis. [PDF]

Sci Rep
Mutithu DW, Kirwan JA, Adeola HA, Aremu OO, Lumngwena EN, Familusi M, Wiesner L, Skatulla S, Naidoo R, Ntusi NAB.   +9 more
europepmc   +1 more source

Mitral Valve Replacement in Children and Adolescents with Rheumatic Heart Disease

, 1976
Stanley John, S C Munsi, I P Sukumar, George Cherian   +3 more
openalex   +2 more sources

Epidemiology of rheumatic heart disease. [PDF]

, 1988
Ayten İmamoğlu, Seval Özen
openalex   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source